Professor Sir Rory Collins, the head of UK Biobank, described a recent incident where medical data from 500,000 participants was listed for sale on a Chinese website as being caused by 'a few bad apples'. The data, consisting of de-identified information, was found on Alibaba but was removed swiftly before any transactions occurred. Collins expressed anger and disappointment over the breach, stating that the institutions involved have been banned from accessing its research platform. In response to the incident, the Biobank temporarily suspended access to its online research platform to implement additional controls aimed at preventing future incidents. The Biobank has been instrumental in advancing research in various health sectors, including dementia and cancer, but the incident raises significant concerns about data security and participant privacy. Sir Rory acknowledged that while it is impossible to eliminate all risks of identification through de-identified data, there is currently no evidence that this has occurred. The organization has referred itself to the Information Commissioner's Office for further inquiry, emphasizing its commitment to protecting individuals' sensitive medical data.
UK Biobank Chief Blames Data Incident on 'Few Bad Apples'
UK Biobank Chief Blames Data Incident on 'Few Bad Apples'
Professor Sir Rory Collins, CEO of UK Biobank, expressed outrage over the recent incident where medical data from 500,000 participants was found for sale online. He emphasized the need for tighter controls to protect sensitive information.
UK Biobank's CEO, Professor Sir Rory Collins, has voiced his anger over a data breach incident that involved the unauthorized sale of medical data belonging to half a million participants. He labeled the culprits as 'a few bad apples', and the organization is currently under scrutiny as they work to enhance data protection measures.
